ADIL
Adial Pharmaceuticals, Inc.Company with tickers: ADIL
CIK
1513525
CUSIP
00688A304
Shares Outstanding
2,188,469
Website
https://adial.com
Investor Relations
https://www.adial.com/investors/
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $976,339 |
| Tony Goodman | COO | $376,198 |
| Joseph A. M. Truluck | CFO | $328,415 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $801,621 |
| Bankole A. Johnson | — | $435,000 |
| Joseph A. M. Truluck | CFO | $389,033 |
| Tony Goodman | COO | $258,932 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Cary Claiborne | CEO | $1,015,938 |
| William B. Stilley | CEO | $591,576 |
| Bankole A. Johnson | — | $489,422 |
| Joseph A. M. Truluck | CFO | $442,620 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,227,856 |
| Joseph A. M. Truluck | CFO | $624,524 |
| Cary Claiborne | CEO | $466,763 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,133,903 |
| Joseph A. M. Truluck | CFO | $451,033 |
| Bankole A. Johnson | — | $375,000 |
| Cary Claiborne | CEO | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $2,366,387 |
| Bankole A. Johnson | — | $1,103,248 |
| Joseph A. M. Truluck | CFO | $727,074 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William B. Stilley | CEO | $1,211,656 |
| Joseph A. M. Truluck | CFO | $308,363 |